BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7684579)

  • 1. Influence of different intravascular volume therapies on platelet function in patients undergoing cardiopulmonary bypass.
    Boldt J; Knothe C; Zickmann B; Andres P; Dapper F; Hempelmann G
    Anesth Analg; 1993 Jun; 76(6):1185-90. PubMed ID: 7684579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy.
    Boldt J; Suttner S; Brosch C; Lehmann A; Röhm K; Mengistu A
    Anesth Analg; 2009 Dec; 109(6):1752-62. PubMed ID: 19923501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of five different priming solutions on platelet function in patients undergoing cardiac surgery.
    Boldt J; Zickmann B; Ballesteros BM; Stertmann F; Hempelmann G
    Anesth Analg; 1992 Feb; 74(2):219-25. PubMed ID: 1731540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Volume loading with hypertonic saline solution: endocrinologic and circulatory responses.
    Boldt J; Knothe C; Zickmann B; Hammermann H; Stertmann WA; Hempelmann G
    J Cardiothorac Vasc Anesth; 1994 Jun; 8(3):317-23. PubMed ID: 7520297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of different volume therapies on platelet function in the critically ill.
    Boldt J; Müller M; Heesen M; Heyn O; Hempelmann G
    Intensive Care Med; 1996 Oct; 22(10):1075-81. PubMed ID: 8923073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemostatic effects of three colloid plasma substitutes for priming solution in cardiopulmonary bypass.
    Tigchelaar I; Gallandat Huet RC; Korsten J; Boonstra PW; van Oeveren W
    Eur J Cardiothorac Surg; 1997 Apr; 11(4):626-32. PubMed ID: 9151028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of different intravascular volume replacement regimens on renal function in the elderly.
    Kumle B; Boldt J; Piper S; Schmidt C; Suttner S; Salopek S
    Anesth Analg; 1999 Nov; 89(5):1124-30. PubMed ID: 10553822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxyethyl starch versus albumin in cardiopulmonary bypass prime solutions.
    Saunders CR; Carlisle L; Bick RL
    Ann Thorac Surg; 1983 Nov; 36(5):532-9. PubMed ID: 6195981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyethyl starch as a priming solution for cardiopulmonary bypass impairs hemostasis after cardiac surgery.
    Kuitunen AH; Hynynen MJ; Vahtera E; Salmenperä MT
    Anesth Analg; 2004 Feb; 98(2):291-297. PubMed ID: 14742357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the carrier solution for hydroxyethyl starch on platelet aggregation and clot formation.
    Schaden E; Wetzel L; Kozek-Langenecker S; Thaler U; Scharbert G
    Br J Anaesth; 2012 Oct; 109(4):572-7. PubMed ID: 22791802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of acute preoperative plasmapheresis on platelet function in cardiac surgery.
    Boldt J; Zickmann B; Ballesteros M; Oehmke S; Stertmann F; Hempelmann G
    J Cardiothorac Vasc Anesth; 1993 Feb; 7(1):4-9. PubMed ID: 8431574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Volume replacement with hydroxyethyl starch solution in children.
    Boldt J; Knothe C; Schindler E; Hammermann H; Dapper F; Hempelmann G
    Br J Anaesth; 1993 Jun; 70(6):661-5. PubMed ID: 7687142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet function in cardiac surgery: influence of temperature and aprotinin.
    Boldt J; Knothe C; Zickmann B; Bill S; Dapper F; Hempelmann G
    Ann Thorac Surg; 1993 Mar; 55(3):652-8. PubMed ID: 7680852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normothermic versus hypothermic cardiopulmonary bypass: do changes in coagulation differ?
    Boldt J; Knothe C; Welters I; Dapper FL; Hempelmann G
    Ann Thorac Surg; 1996 Jul; 62(1):130-5. PubMed ID: 8678631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of hypertonic volume replacement on the microcirculation in cardiac surgery.
    Boldt J; Zickmann B; Herold C; Ballesteros M; Dapper F; Hempelmann G
    Br J Anaesth; 1991 Nov; 67(5):595-602. PubMed ID: 1721516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of intravascular volume therapy with a new hydroxyethyl starch preparation (6% HES 130/0.4) on coagulation in patients undergoing major abdominal surgery.
    Haisch G; Boldt J; Krebs C; Kumle B; Suttner S; Schulz A
    Anesth Analg; 2001 Mar; 92(3):565-71. PubMed ID: 11226079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of different colloids on molecular markers of haemostasis and platelet function in patients undergoing major abdominal surgery.
    Hüttner I; Boldt J; Haisch G; Suttner S; Kumle B; Schulz H
    Br J Anaesth; 2000 Sep; 85(3):417-23. PubMed ID: 11103184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence on coagulation of a potato-derived hydroxethylstarch (HES 130/0.42) and a maize-derived hydroxethylstarch (HES 130/0.4) in patients undergoing cardiac surgery.
    Boldt J; Suttner S; Brosch C; Lehmann A; Mengistu A
    Br J Anaesth; 2009 Feb; 102(2):191-7. PubMed ID: 19074154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the haemodynamic effects of 4% succinylated gelatin, 6% hydroxyethyl starch (200/0.5) and 4% human albumin after cardiac surgery.
    Kuitunen A; Suojaranta-Ylinen R; Kukkonen S; Niemi T
    Scand J Surg; 2007; 96(1):72-8. PubMed ID: 17461317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of 6% hydroxyethyl starch 130/0.4 (Voluven) for perioperative volume replacement in children undergoing cardiac surgery: a propensity-matched analysis.
    Van der Linden P; Dumoulin M; Van Lerberghe C; Torres CS; Willems A; Faraoni D
    Crit Care; 2015 Mar; 19(1):87. PubMed ID: 25886765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.